Kerstin Moehle

USPTO Granted Patents = 15 (Patent Applications = 2)

CIPO Patents = 13

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 9.7

ph-index = 6

Forward Citations = 71(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2010-2022

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11421001 - Template-fixed peptidomimetics (2022-08-23),

2. 10787486 - Template-fixed peptidomimetics (2020-09-29),

3. 10730911 - Backbone-cyclized peptidomimetics with GLP-1R modulating activity (2020-08-04),

4. 10562933 - Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity (2020-02-18),

5. 10144765 - Template-fixed peptidomimetics (2018-12-04),

6. 10100084 - Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity (2018-10-16),

7. 9879047 - Template-fixed peptidomimetics (2018-01-30),

8. 9556234 - Template-fixed peptidomimetics (2017-01-31),

9. 9518092 - Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity (2016-12-13),

10. 8921325 - Template-fixed peptidomimetics (2014-12-30),

11. 8895695 - Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity (2014-11-25),

12. 8658604 - Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity (2014-02-25),

13. 8399611 - Template-fixed peptidomimetics (2013-03-19),

14. 7838496 - Template-fixed peptidomimetics as medicaments against HIV and cancer (2010-11-23),

15. 7786078 - Template-fixed δ-hairpin peptidomimetics with CXCR4 antagonizing activity (2010-08-31),

Title: The Innovative Journey of Kerstin Moehle

Introduction

Kerstin Moehle, an accomplished inventor based in Wettswil, Switzerland, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 15 patents, she is recognized for her groundbreaking work in developing novel peptidomimetics that hold promising potential in cancer therapy.

Latest Patents

Kerstin's latest patents focus on template-fixed β-hairpin peptidomimetics, specifically the compound Cyclo(-Tyr-His-X-Cys-Ser-Ala-Pro-Dab-Arg-Tyr-Cys-Tyr-Gln-Lys-Pro-Pro). This innovative design features a disulfide bond between Cys4 and Cys11 and includes pharmaceutically acceptable salts with X being either Ala or Tyr. These compounds exhibit CXCR4 antagonizing properties, suggesting their utility in treating cancers associated with CXCR4 receptor activity.

Career Highlights

Throughout her career, Kerstin has demonstrated her prowess as an inventor while working with reputable organizations such as Polyphor Ltd. and the University of Zurich. Her work has not only advanced scientific understanding but also positioned her as a valuable contributor to the ongoing fight against cancer.

Collaborations

Kerstin has collaborated with notable individuals in her field, including Daniel Obrecht and Steven J. Demarco. These partnerships have played a critical role in fostering innovation and developing her patented technologies.

Conclusion

Kerstin Moehle's contributions to the field of pharmaceutical innovations highlight her dedication and expertise as an inventor. Her groundbreaking patent work in template-fixed β-hairpin peptidomimetics marks a significant advancement in therapeutic options for cancer treatment, showcasing her role as a key figure in the scientific community.

This text is generated by artificial intelligence and may not be accurate.